Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells

Nucleic Acids Research

Volumn 41, Issue 11, 2013, Pages 5614-5625

  Lee, Ji Young ^a   Kim, Hyo Jeong ^a   Yoon, Nal Ae ^a   Lee, Won Hyeok ^b   Min, Young Joo ^b   Ko, Byung Kyun ^b   Lee, Byung Ju ^a   Lee, Aran ^b   Cha, Hee Jeong ^b   Cho, Wha Ja ^b   Park, Jeong Woo ^a  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOXORUBICIN; LET 7 PROTEIN; MICRORNA; PROTEIN; PROTEIN P53; SMALL INTERFERING RNA; TRISTETRAPROLIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; DNA DAMAGE; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; ONCOGENE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MUTATION; PROMOTER REGIONS, GENETIC; RNA-BINDING PROTEINS; TRISTETRAPROLIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878874654     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt222     Document Type: Article

References (42)

1. Riley, T., Sontag, E., Chen, P. and Levine, A. (2008) Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol., 9, 402-412.
2. Vogelstein, B., Lane, D. and Levine, A.J. (2000) Surfing the p53 network. Nature, 408, 307-310.
3. Vousden, K.H. and Lu, X. (2002) Live or let die: the cell's response to p53. Nat. Rev. Cancer, 2, 594-604.
4. Soussi, T. and Beroud, C. (2001) Assessing TP53 status in human tumours to evaluate clinical outcome. Nat. Rev. Cancer, 1, 233-240.
5. Sbisa, E., Catalano, D., Grillo, G., Licciulli, F., Turi, A., Liuni, S., Pesole, G., De Grassi, A., Caratozzolo, M.F., D'Erchia, A.M. et al. (2007) p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data. BMC Bioinformatics, 8(Suppl.1), S20.
6. Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
7. Kumar, M.S., Lu, J., Mercer, K.L., Golub, T.R. and Jacks, T. (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet., 39, 673-677.
8. He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
9. Braun, C.J., Zhang, X., Savelyeva, I., Wolff, S., Moll, U.M., Schepeler, T., Orntoft, T.F., Andersen, C.L. and Dobbelstein, M. (2008) p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res., 68, 10094-10104.
10. Chang, T.C., Wentzel, E.A., Kent, O.A., Ramachandran, K., Mullendore, M., Lee, K.H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C.J. et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 26, 745-752.
11. Suzuki, H.I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S. and Miyazono, K. (2009) Modulation of microRNA processing by p53. Nature, 460, 529-533.
12. Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G. and Hermeking, H. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 6, 1586-1593.
13. Esquela-Kerscher, A. and Slack, F.J. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
14. Heo, I., Joo, C., Cho, J., Ha, M., Han, J. and Kim, V.N. (2008) Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell, 32, 276-284.
15. Viswanathan, S.R., Daley, G.Q. and Gregory, R.I. (2008) Selective blockade of microRNA processing by Lin28. Science, 320, 97-100.
16. Viswanathan, S.R., Powers, J.T., Einhorn, W., Hoshida, Y., Ng, T.L., Toffanin, S., O'Sullivan, M., Lu, J., Phillips, L.A., Lockhart, V.L. et al. (2009) Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet., 41, 843-848.
17. Shaw, G. and Kamen, R. (1986) A conserved AU sequence from the 30 untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46, 659-667.
18. Shyu, A.B. and Wilkinson, M.F. (2000) The double lives of shuttling mRNA binding proteins. Cell, 102, 135-138.
19. Carballo, E., Lai, W.S. and Blackshear, P.J. (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science, 281, 1001-1005.
20. Lykke-Andersen, J. and Wagner, E. (2005) Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev., 19, 351-361.
21. Kim, C.W., Vo, M.T., Kim, H.K., Lee, H.H., Yoon, N.A., Lee, B.J., Min, Y.J., Joo, W.D., Cha, H.J., Park, J.W. et al. (2012) Ectopic over-expression of tristetraprolin in human cancer cells promotes biogenesis of let-7 by down-regulation of Lin28. Nucleic Acids Res., 40, 3856-3869.
22. Brennan, S.E., Kuwano, Y., Alkharouf, N., Blackshear, P.J., Gorospe, M. and Wilson, G.M. (2009) The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res., 69, 5168-5176.
23. Harris, C.C. and Hollstein, M. (1993) Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med., 329, 1318-1327.
24. Yang, X.H., Sladek, T.L., Liu, X., Butler, B.R., Froelich, C.J. and Thor, A.D. (2001) Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin-and etoposide-induced apoptosis. Cancer Res., 61, 348-354.
25. Ling, Y.H., el-Naggar, A.K., Priebe, W. and Perez-Soler, R. (1996) Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol. Pharmacol., 49, 832-841.
26. Zimmermann, M., Arachchige-Don, A.S., Donaldson, M.S., Dallapiazza, R.F., Cowan, C.E. and Horne, M.C. (2012) Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin. J. Biol. Chem., 287, 22838-22853.
27. Lee, H.H., Vo, M.T., Kim, H.J., Lee, U.H., Kim, C.W., Kim, H.K., Ko, M.S., Lee, W.H., Cha, S.J., Min, Y.J. et al. (2010) Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin. J. Biol. Chem., 285, 17329-17337.
28. Singal, P.K. and Iliskovic, N. (1998) Doxorubicin-induced cardiomyopathy. N. Engl. J. Med., 339, 900-905.
29. Wang, S., Konorev, E.A., Kotamraju, S., Joseph, J., Kalivendi, S. and Kalyanaraman, B. (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)-and p53-dependent pathways. J. Biol. Chem., 279, 25535-25543.
30. Toledo, F. and Wahl, G.M. (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer, 6, 909-923.
31. Heo, I., Joo, C., Kim, Y.K., Ha, M., Yoon, M.J., Cho, J., Yeom, K.H., Han, J. and Kim, V.N. (2009) TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell, 138, 696-708.
32. Al-Haj, L., Blackshear, P.J. and Khabar, K.S.A. (2012) Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements. Nucleic Acids Res., 40, 7739-7752.
33. Marderosian, M., Sharma, A., Funk, A.P., Vartanian, R., Masri, J., Jo, O.D. and Gera, J.F. (2006) Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene, 25, 6277-6290.
34. Hau, H.H., Walsh, R.J., Ogilvie, R.L., Williams, D.A., Reilly, C.S. and Bohjanen, P.R. (2007) Tristetraprolin recruits functional mRNA decay complexes to ARE sequences. J. Cell Biochem., 100, 1477-1492.
35. Kim, C.W., Kim, H.K., Vo, M.T., Lee, H.H., Kim, H.J., Min, Y.J., Cho, W.J. and Park, J.W. (2010) Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 30UTR of cIAP2 mRNA. Biochem. Biophys. Res. Commun., 400, 46-52.
36. Krecic, A.M. and Swanson, M.S. (1999) hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol., 11, 363-371.
37. Dreyfuss, G., Kim, V.N. and Kataoka, N. (2002) Messenger-RNAbinding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol., 3, 195-205.
38. Meyer, S., Temme, C. and Wahle, E. (2004) Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit. Rev. Biochem. Mol. Biol., 39, 197-216.
39. Singh, R. and Valcá rcel, J. (2005) Building specificity with nonspecific RNA-binding proteins. Nat. Struct. Mol. Biol., 12, 645-653.
40. Chang, W.L. and Tarn, W.Y. (2009) A role for transportin in deposition of TTP to cytoplasmic RNA granules and mRNA decay. Nucleic Acids Res., 37, 6600-6612.
41. Lowe, S.W., Bodis, S., McClatchey, A., Remington, L., Ruley, H.E., Fisher, D.E., Housman, D.E. and Jacks, T. (1994) p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810.
42. Purvis, J.E., Karhohs, K.W., Mock, C., Batchelor, E., Loewer, A. and Lahav, G. (2012) p53 dynamics control cell fate. Science, 336, 1440-1444.